Overexpression of CSNK1A1 can promote the proliferation and survival of tumor cells by downregulating the expression of CTNNB1 in myeloma [31]; CSNK1A1 and CTNNB1 both function in the classic Wnt/β-catenin signaling pathway. Here, CTNNB1 is linked to plasma cell myeloma.